universalpennystocks.com focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny Stocks could offer the greatest potential return on your short or long term investment. Sign up for our free newsletter before you miss the next alert.
ExelisInc (NYSE:XLS) reported 2012 financial results for the fourth quarter and full year of 2012. Fourth-quarter revenue was $1.4 billion, dropped 8 percent from the fourth quarter of 2011. Earnings were $0.45 per share, a 32 percent upsurge from the fourth quarter of 2011. Adjusted earnings were $0.47 per share for the fourth quarter, a 6 percent reduction from the same period in 2011. The company generated $259 million in free cash flow in the quarter.
In the last trading session, ExelisInc (NYSE:XLS) gained +2.33% and closed at $10.56 with the overall traded volume of 5.26 million shares.
Pepco Holdings, Inc. (NYSE:POM) recently reported fourth quarter results. GAAP earnings from ongoing operations were $285 million compared to $260 million in 2011. Power Delivery earnings improved year-over-year mainly due to higher electric transmission and distribution revenue resulting from higher rates driven by increased investment in arrangement.
In the last trading session, Pepco Holdings, Inc. (NYSE:POM) surged +1.18% to close at $20.53 and its total traded volume was 2.74 million shares more than the average volume of 1.90 million.
Hospitality Properties Trust (NYSE:HPT) declared its financial results for the quarter and year ended December 31, 2012. Normalized funds from operations for the quarter ended December 31, 2012 were $93.9 million, or $0.76 per share. Net income for common shareholders was $18.5 million, or $0.15 per share, for the quarter ended December 31, 2012, compared to $30.7 million, or $0.25 per share, for the quarter ended December 31, 2011.
Novavax, Inc. (NASDAQ:NVAX) declared financial results for the fourth quarter and year-ended December 31, 2012. For the fourth quarter of 2012, Novavax reported a net loss of $8.0 million, or $0.06 per share. The rise in the net loss in 2012 compared to 2011 was mainly a result of higher research and development spending, together withaugmented costs related to respiratory syncytial virus (RSV) clinical trials, higher employee-related costs and expenses relatedto the company's new manufacturing facility.
In the last trading session, Novavax, Inc. (NASDAQ:NVAX) jumped +0.55% and closed at $1.83.About Universal Penny Stocks
universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.